glp-1 receptor in brain expressing cells the CNS. A, B. Demonstrates the GLP-1 Receptor Agonists in Neurodegeneration:

hazard ratio 0.35, 0.15 to 0.80) and a 43% lower risk of heart failure (3.6 v 6.1 per 1000 person years

Vad r GLP-1

The role of diabetes and weight-loss medications in treating alcohol use disorder

Consequently, the oxidized nicotinamide adenine dinucleotide/ATP ratio is depleted, and glyceraldehyde-3-phosphate dehydrogenase is inactivated, leading to the activation of harmful pathways such as the polyol, hexosamine and protein kinase C (PKC) pathways, as well as the subsequent accumulation of advanced glycation end products, resulting in microvascular damage

Testing the effects of the GLP-1 receptor agonist Exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder